webinar
Oct. 27-28, 2025, Boston, MA, USA - Booth 114.
Read More

mPEG3-amine

  CAS No.: 74654-07-2   Cat No.: BADC-01149   Purity: ≥95% HNMR MS 4.5  

mPEG3-amine is a short-chain, amine-functionalized PEG linker offering compact size for ADC applications. Enhances solubility and stability of antibody-drug complexes while minimizing steric hindrance.

mPEG3-amine

Structure of 74654-07-2

Quality
Assurance

Worldwide
Delivery

24/7 Customer
Support
Category
ADC Linker
Molecular Formula
C7H17NO3
Molecular Weight
163.21
Shipping
Room temperature, or blue ice upon request.
Shipping
Store at 2-8°C

* For research and manufacturing use only. We do not sell to patients.

Size Price Stock Quantity
-- $-- In stock

Looking for different specifications? Click to request a custom quote!

Capabilities & Facilities

Popular Publications Citing BOC Sciences Products
Synonyms
m-PEG3-amine; 2-[2-(2-Methoxyethoxy)ethoxy]ethylamine; mPEG3-NH2; 2-(2-(2-methoxyethoxy)ethoxy)ethan-1-amine; Ethanamine, 2-[2-(2-methoxyethoxy)ethoxy]-; Methyl-PEG3-amine; 3,6,9-Trioxadecane-1-amine; 3,6,9-Trioxa-1-aminodecane
IUPAC Name
2-[2-(2-methoxyethoxy)ethoxy]ethanamine
Canonical SMILES
COCCOCCOCCN
InChI
InChI=1S/C7H17NO3/c1-9-4-5-11-7-6-10-3-2-8/h2-8H2,1H3
InChIKey
OKUWOEKJQRUMBW-UHFFFAOYSA-N
Density
0.978±0.06 g/cm3 (Predicted)
Solubility
Soluble in DCM, DMF, DMSO, Water
Flash Point
86.1°C
Index Of Refraction
1.431
PSA
53.71000
Appearance
Pale Yellow or Colorless Oily Matter
Shelf Life
0-4°C for short term (days to weeks), or -20°C for long term (months).
Shipping
Room temperature, or blue ice upon request.
Storage
Store at 2-8°C
Pictograms
Irritant
Signal Word
Warning
Boiling Point
223.9±20.0°C at 760 mmHg
Form
Solid
Biological Activity
m-PEG3-Amine is a cleavable ADC linker used in the synthesis of antibody-drug conjugates (ADCs)[1] . In Vitro: ADCs are comprised of an antibody to which is attached an ADC cytotoxin through an ADC linker.

mPEG3-amine, also referred to as methoxy-polyethylene glycol (mPEG) with an amine group, stands out as a remarkably versatile bioconjugation reagent, extensively applied in biosciences. Let’s delve into the myriad applications of mPEG3-amine:

Bioconjugation: Within the intricate realm of bioconjugation, mPEG3-amine plays a pivotal role in enhancing the properties of proteins, peptides, and small molecules. By conjugating mPEG3-amine to therapeutic compounds, researchers can elevate their solubility, stability, and circulatory half-life, heralding a new era in biotherapeutics development.

Drug Delivery: In the dynamic domain of drug delivery, mPEG3-amine emerges as a transformative agent in the modification of nanoparticles and drug carriers. Through PEGylation, these carriers can stealthily navigate past the immune system, prolonging their circulation time and improving the delivery of therapeutic payloads. This innovation significantly enhances the precision of drug targeting and therapeutic efficacy, especially in the fight against cancer and chronic ailments, showcasing the revolutionary potential of mPEG3-amine in healthcare.

Surface Modification: The versatile nature of mPEG3-amine holds critical significance in the realm of surface modification of biomaterials to augment their biocompatibility. By coating surfaces with biocompatible and non-immunogenic PEG, the propensity for protein absorption and cell adhesion diminishes significantly, paving the way for advanced medical devices and implant development. This application plays a vital role in reducing foreign body reactions, underscoring the essential importance of mPEG3-amine in medical technology.

Bioconjugation Chemistry Research: Serving as a foundational element in bioconjugation chemistry research, mPEG3-amine acts as a key model compound for exploring and optimizing bioconjugation reactions. Researchers leverage mPEG3-amine to delve into diverse coupling reactions, evaluating their efficiencies and specificities across various functional groups. This profound understanding aids in designing highly efficient conjugation strategies for complex biomolecules in both research and therapeutic settings.

The molarity calculator equation

Mass (g) = Concentration (mol/L) × Volume (L) × Molecular Weight (g/mol)

The dilution calculator equation

Concentration (start) × Volume (start) = Concentration (final) × Volume (final)

This equation is commonly abbreviated as: C1V1 = C2V2

Related Products

Contact our experts today for pricing and comprehensive details on our ADC offerings.

You May Also Be Interested In

From cytotoxin synthesis to linker design, discover our specialized services that complement your ADC projects.

ADC Linker Development Enzyme Cleavable Linker Cathepsin B Cleavable Linker/Peptide Linker Phosphatase Cleavable Linker β-Glucuronide Linker β-Galactosidase Cleavable Linker Sulfatase Cleavable Linker Chemically Cleavable Linker Non-Cleavable Linker Services Acid Cleavable Linker/Hydrazone Linker

Unlock Deeper ADC Insights

Learn more about payload design, linker strategies, and integrated CDMO support through our curated ADC content.

Linkers - A Crucial Factor in Antibody–Drug Conjugates In-Depth Review of ADC Linkers: Types, Mechanisms, and Research Progress New Structural Insights Solve Instability Issues of Maleimide Linkers in ADCs PEG Linkers in Antibody-Drug Conjugates Peptide Linkers in Antibody-Drug Conjugates Disulfide Linkers in Antibody-Drug Conjugates Biotinylation Reagents in Antibody-Drug Conjugates Maleimide Linkers in Antibody-Drug Conjugates Current ADC Linker Chemistry SPDB Linkers in Antibody-Drug Conjugates

Explore More ADC Products

Find exactly what your project needs from our expanded range of ADCs, offering flexible options to fit your timelines and goals.

ADC Cytotoxin

Powerful Targeted Cancer Solutions

ADC  Cytotoxin with Linker

Enhanced Stability And Efficacy

ADC Linker

Precise Conjugation For Success

Antibody-Drug  Conjugates (ADCs)

Maximized Therapeutic Performance

Auristatins

Next-Level Tubulin Inhibition

Calicheamicins

High-Impact DNA Targeting

Camptothecins

Advanced Topoisomerase Inhibition

Daunorubicins / Doxorubicins

Trusted Anthracycline Payloads

Duocarmycins

Potent DNA Alkylation Agents

Maytansinoids

Superior Microtubule Disruption

Pyrrolobenzodiazepines

Ultra-Potent DNA Crosslinkers

Traditional Cytotoxic Agents

Proven Chemotherapy Solutions

Cleavable Linker

Precise Intracellular Drug Release

Non-Cleavable Linker

Exceptional Long-Term Stability

Historical Records: SC209 intermediate-2 | Boc-cis-L-4-hydroxyproline methyl ester | EC1167 hydrochloride | Fmoc-D-Trp(Boc)-OH | MAL-tri-EG-OPFP | Methyl azetidine-3-carboxylate hydrochloride | Hydroxy-PEG3-t-butyl ester | Me-Tet-PEG2-COOH | Boc-D-Lys(N3)-OH CHA salt | Boc-Dap-OH.DCHA | mPEG3-amine
Send Inquiry
Verification code
Inquiry Basket